AstraZeneca’s Imfinzi Trial Shows Survival In Lung Cancer Patients
Moderna broadens R&D scope with Vertex, Chiesi alliances
NIH launches trial of Rigel drug for severe Covid-19
3 "Strong Buy" Healthcare Stocks With Major Catalysts Approaching
Eli Lilly Strikes Deal With Amgen To Manufacture Covid-19 Antibody Therapies
Biomarker predicts who will have severe COVID-19
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
Connected fitness startup Tonal raises another $110 million
Lilly’s antibody therapy cuts hospitalisation rates in COVID-19
British-made surgical PPE device rolls out free to NHS
Morgan Stanley Bets on These 3 Stocks; Sees Over 40% Upside
Reimagining Content for a COVID world: Ten Critical Dos and Don’ts for Brands
Inhale, Exhale: Living with Severe Asthma and Severe Eosinophilic Asthma
Eli Lilly’s Antibody Therapy Against Covid-19 Reduced Hospitalization Rates
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
Oppenheimer: 3 Stocks That Could Surge Over 100% From Current Levels
Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub
Henry ford study finds certain immuno suppressing drugs do not increase risk for COVID-19
Merck To Buy $1B Seattle Genetics Stake For Oncology Collab
Morgan Stanley: 2 Strong Value Stocks to Buy Now
These 3 Penny Stocks Could Double (Or More), Says BTIG
Futures Surge On Monday Merger Mania, Fresh Vaccine Hopes
Regeneron, Sanofi’s Dupixent Nabs Breakthrough Tag For Esophagus Disease
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Price cut wins NICE OK for AZ’s Tagrisso in untreated lung cancer
Antibody test developed for COVID-19 that is sensitive, specific and scalable
Savara's long-reigning duo both resign in the wake of CF bust